Longeveron (LGVN) EBITDA Margin (2020 - 2026)
Longeveron (LGVN) recorded EBITDA Margin of -2073.17% in Q2 2026, down 448.49 percentage points from -1624.68% a year earlier and down 936.74 percentage points from the prior quarter.
Powered by 
Analysis
Longeveron (LGVN) EBITDA Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Longeveron's EBITDA Margin came in at -1907.33% as of Jun 30, 2026, down 1022.28 percentage points year-over-year; for FY2025, it came in at -1839.95%, down 1189.28 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -1786.78 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -650.67% in FY2024 (+2181.91 pp), -2832.58% in FY2023 (-1429.14 pp), -1403.44% in FY2022 (-136.82 pp) and -1266.62% in FY2021 (-1213.44 pp).
- Quarterly EBITDA Margin has ranged from -8260.32% in Q4 2023 to -571.02% in Q3 2024 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in three of the last eight quarters, with an average year-over-year change of +398.74 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 7590.50 percentage points in Q4 2024, against a drop of 4572.04 percentage points in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -1136.43% (Q1 2026), -1403.01% (Q4 2025) and -5143.07% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Longeveron | 8.14 Mn | -31.66 Mn | 182,000.00 | -2,073.17% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,073.17% |
| Mar 31, 2026 | -1,136.43% |
| Dec 31, 2025 | -1,403.01% |
| Sep 30, 2025 | -5,143.07% |
| Jun 30, 2025 | -1,624.68% |
| Mar 31, 2025 | -1,249.34% |
| Dec 31, 2024 | -669.82% |
| Sep 30, 2024 | -571.02% |
| Jun 30, 2024 | -698.93% |
| Mar 31, 2024 | -700.36% |
| Dec 31, 2023 | -8,260.32% |
| Sep 30, 2023 | -3,286.00% |
| Jun 30, 2023 | -2,521.66% |
| Mar 31, 2023 | -1,605.02% |
| Dec 31, 2022 | -4,136.36% |
| Sep 30, 2022 | -1,866.79% |
| Jun 30, 2022 | -856.65% |
| Mar 31, 2022 | -866.49% |
| Dec 31, 2021 | -1,818.18% |
| Sep 30, 2021 | -2,012.50% |
API Access
Longeveron EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LGVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "LGVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LGVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();